MedTrace Logo

Development of an Algorithm to Better Predict Clinical Responsiveness to Peanut

NCT00243555 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2007-02-01

No results posted yet for this study

Summary

The purpose of this study is to develop a tool to better predict clinical allergy to peanut, so that those who are skin test positive but non allergic will not have to unnecessarily avoid peanut, and those with true allergy can be diagnosed, possibly without oral ingestion challenge, and treated appropriately

Conditions

  • Peanut Hypersensitivity

Interventions

PROCEDURE

allergy skin testing

PROCEDURE

venepuncture

Sponsors & Collaborators

  • Food Allergy Initiative

    collaborator OTHER

  • AllerGen NCE Inc.

    collaborator INDUSTRY

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Susan Waserman, MSc, MD, FRCPC · Hamilton Health Sciences Corporation, McMaster Site

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00243555 on ClinicalTrials.gov